Implantable closed-loop glucose-sensing and insulin delivery: The future for insulin pump therapy

Current Opinion in Pharmacology

Volumn 2, Issue 6, 2002, Pages 708-716

  Renard, Eric ^a  

^a LAPEYRONIE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; INSULIN; INSULIN LISPRO; ANTIDIABETIC AGENT;

ACCURACY; BIOSENSOR; BLOOD GLUCOSE MONITORING; BLOOD VESSEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE REMOVAL; DISEASE SEVERITY; DRUG DELIVERY SYSTEM; ELECTRONIC SENSOR; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; HYPOGLYCEMIC COMA; INCIDENCE; INFUSION PUMP; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INTERMETHOD COMPARISON; KETOACIDOSIS; PRIORITY JOURNAL; REVIEW; SKIN DEFECT; DIABETES MELLITUS; GENETIC PROCEDURES; METHODOLOGY;

BIOSENSING TECHNIQUES; BLOOD GLUCOSE; DIABETES MELLITUS; HUMANS; HYPOGLYCEMIC AGENTS; INFUSION PUMPS, IMPLANTABLE; INSULIN;

EID: 0036902299     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4892(02)00216-3     Document Type: Review

References (81)

1. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993, 329:977-986.
2. The Diabetes Control and Complications Trial Research Group: Influence of intensive diabetes treatment on quality-of-life outcomes in the Diabetes Control and Complications Trial. Diabetes Care 1996, 19:195-203.
3. Selam JL, Charles MA: Devices for insulin administration. Diabetes Care 1990, 13:955-979.
4. Landgraf R: Impact of pancreas transplantation on diabetic secondary complications and quality of life. Diabetologia 1996, 39:1415-1424.
5. Shapiro AMJ, Lakey JRT, Ryan EA, Korbutt GS, Toth EL, Warnock GL, Kneteman NM, Rajotte RV: Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000, 343:230-238.
6. Jaremko J, Rorstad O: Advances toward the implantable artificial pancreas for treatment of diabetes. Diabetes Care 1998, 2:444-450.
7. Pickup J, Keen H: Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes. Diabetes Care 2002, 25:593-598.
8. Pickup J, Mattock M, Kerry S: Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials. BMJ 2002, 324:705.
9. Bode BW, Sabbah HT, Gross TM, Fredrickson LP, Davidson PC: Diabetes management in the new millennium using insulin pump therapy. Diabetes Metab Res Rev 2002, 18(Suppl 1):14-20.
10. Lenhard MJ, Reeves GD: Continuous subcutaneous insulin infusion: a comprehensive review of insulin pump therapy. Arch Intern Med 2001, 161:2293-2300.
11. Mecklenburg RS, Benson JW Jr, Becker NM, Brazel PL, Fredlund PN, Metz RJ, Nielsen RL, Sanner CA, Steenrod WJ Jr: Clinical use of the insulin infusion pump in 100 patients with type 1 diabetes. N Engl J Med 1982, 307:513-518.
12. Daubresse JC, Henrivaux P, Bailly A, Lemy C, Duchateau A: Long-term management of insulin-treated diabetic patients with continuous subcutaneous insulin infusion. Diabetes Metab 1983, 9:45-52.
13. Mecklenburg RS, Benson EA, Benson JW Jr, Fredlund PN, Guinn T, Metz RJ, Nielsen RL, Sanner CA: Acute complications associated with insulin infusion pump therapy. Report of experience with 181 patients. J Am Med Assoc 1984, 252:3265-3269.
14. Locke DR, Rigg LA: Hypoglycemic coma associated with subcutaneous insulin infusion by portable pump. Diabetes Care 1981, 4:389-391.
15. The Diabetes Control and Complications Trial Research Group: Implementation of treatment protocols in the Diabetes Control and Complications Trial. Diabetes Care 1995, 18:361-376.
16. Bending JJ, Pickup JC, Keen H: Frequency of diabetic ketoacidosis and hypoglycemic coma during treatment with subcutaneous insulin infusion. Am J Med 1985, 79:685-691.
17. Ng Tang Fui S, Pickup JC, Bending JJ, Collins ACG, Keen H, Dalton N: Hypoglycemia and counterregulation in insulin-dependent diabetic patients: a comparison of continuous subcutaneous insulin infusion and conventional insulin therapy. Diabetes Care 1986, 9:221-227.
18. Bode BW, Steed RD, Davidson PC: Reduction in severe hypoglycemia with long-term subcutaneous insulin infusion in type 1 diabetes. Diabetes Care 1996, 19:324-327.
19. Rowe R: Insulin pump therapy. Diabet Med 2001, 18(Suppl 4):4-5.
20. Tamborlane WV, Bonfig W, Boland E: Recent advances in treatment of youth with Type 1 diabetes: better care through technology. Diabet Med 2002, 18:864-870.
21. Hanas R: Selection for and initiation of continuous subcutaneous insulin infusion. Proceedings from a workshop. Horm Res 2002, 57(Suppl 1):101-104.
22. Conrad SC, McGrath MT, Gitelman SE: Transition from multiple daily injections to continuous subcutaneous insulin infusion in type 1 diabetes mellitus. J Pediatr 2002, 140:235-240.
23. Raile K, Noelle V, Landgraf R, Schwarz HP: Weight in adolescents with type 1 diabetes mellitus during continuous subcutaneous insulin infusion (CSII) therapy. J Pediatr Endocrinol Metab 2002, 15:607-612.
24. Simmons D, Thompson CF, Conroy C, Scott DJ: Use of insulin pumps in pregnancies complicated by type 2 diabetes and gestational diabetes in a multiethnic community. Diabetes Care 2001, 24:2078-2082.
25. Zinman B, Tildesley H, Chiasson JL, Tsui E, Strack T: Insulin lispro in CSII: results of double-blind crossover study. Diabetes 1997, 46:440-443.
26. Melki V, Renard E, Lassmann-Vague V, Boivin S, Guerci B, Hanaire-Broutin H, Bringer J, Belicar P, Jeandidier N, Meyer L et al.: Improvement of HbA1c and blood glucose stability in IDDM patients treated with lispro insulin analog in external pumps. Diabetes Care 1998, 21:977-982.
27. Raskin P, Holcombe JH, Tamborlane WV, Malone JI, Strowig S, Ahern JA, Lavent F: A comparison of insulin lispro and buffered regular human insulin administered via continuous subcutaneous insulin infusion pump. J Diabetes Complications 2001, 15:295-300.
28. Meece JD, Campbell RK: Insulin lispro update. Diabetes Educ 2002, 28:269-277.
29. Schade DS, Eaton RP, Davis T, Akiya F, Phinney E, Kubica R, Vaughn E, Pay PW: The kinetics of peritoneal insulin absorption. Metabolism 1981, 30:149-155.
30. Nelson JA, Stephen R, Landau ST, Wilson DE, Tyler FH: Intraperitoneal insulin administration produces a positive portalsystemic blood insulin gradient in unanesthetized, unrestrained swine. Metabolism 1982, 31:969-972.
31. Point Study Group: One-year trial of a remote-controlled implantable insulin infusion system in type I diabetic patients. Lancet 1988, i:864-869.
32. Saudek CD, Selam JL, Pitt HA, Waxman K, Rubio M, Jeandidier N, Turner D, Fishell RE, Charles MA: A preliminary trial of the programmable implantable medication system for insulin delivery. N Engl J Med 1989, 321:574-579.
33. Selam JL, Micossi P, Dunn FL, Nathan DM: Clinical trial of programmable implantable insulin pumps for type 1 diabetes. Diabetes Care 1992, 15:877-885.
34. Hanaire-Broutin H, Broussolle C, Jeandidier N, Renard E, Guerci B, Haardt MJ, Lassmann-Vague V: The EVADIAC Study Group : Feasibility of intraperitoneal insulin therapy with programmable implantable pumps in IDDM: A multicenter study. Diabetes Care 1995, 18:388-392.
35. Selam JL: External and implantable insulin pumps: current place in the treatment of diabetes. Exp Clin Endocrinol Diabetes 2001, 109(Suppl 2):S333-S340.
36. Renard E, Bringer J, Jacques-Apostol D, Lauton D, Mestre C, Costalat G, Jaffiol C: Complications of the pump-pocket may represent a significant cause of incidents with implanted systems for intraperitoneal insulin delivery. Diabetes Care 1994, 17:1064-1066.
37. Renard E, Rostane T, Carriere C, Marchandin H, Jacques-Apostol D, Lauton D, Gibert-Boulet F, Bringer J: Implantable insulin pumps: infections most likely due to seeding from skin flora determine severe outcomes of pump-pocket seromas. Diabetes Metab 2001, 27:62-65.
38. Renard E, Bouteleau S, Jacques-Apostol D, Lauton D, Boulet-Gibert F, Costalat G, Bringer J, Jaffiol C: Insulin underdelivery from implanted pumps using peritoneal route: determinant role of insulin-pump compatibility. Diabetes Care 1996, 19:812-817.
39. Grau U, Saudek CD: Stable insulin preparation for implanted insulin pumps. Laboratory and animal trials. Diabetes 1987, 36:1453-1459.
40. Jeandidier N, Boivin S, Sapin R, Rosart-Ortega F, Uring-Lambert B, Reville P, Pinget M: Immunogenicity of intraperitoneal insulin infusion using programmable implantable devices. Diabetologia 1995, 38:577-584.
41. Jeandidier N, Boullu S, Busch-Brafin MS, Chabrier G, Sapin R, Gasser F, Pinget M: Comparison of antigenicity of Hoechst 21PH insulin using either implantable intraperitoneal pump or subcutaneous external pump infusion in type 1 diabetic patients. Diabetes Care 2002, 25:84-88.
42. Renard E, Baldet P, Picot MC, Jacques-Apostol D, Lauton D, Costalat G, Bringer J, Jaffiol C: Catheter complications with implantable systems for peritoneal insulin delivery. An analysis of frequency, predisposing factors and obstructing materials. Diabetes Care 1995, 18:300-306.
43. Renard E, Souche C, Jacques-Apostol D, Lauton D, Gibert-Boulet F, Costalat G, Bringer J, Jaffiol C: Improved stability of insulin delivery from implanted pumps using a new preparation process for infused insulin. Diabetes Care 1999, 22:1371-1372.
44. Gin H, Melki V, Guerci B, Catargi B: The EVADIAC Study Group: clinical evaluation of a newly designed compliant side port catheter for an insulin implantable pump: the EVADIAC experience. Diabetes Care 2001, 24:175.
45. Catargi B, Meyer L, Melki V, Renard E, Jeandidier N for the EVADIAC Study Group: Comparison of blood glucose stability and HbA1c between implantable insulin pumps using U400 HOE 21Ph insulin and external pumps using lispro in type 1 diabetic patients: a pilot study. Diabetes Metab 2002, 28:133-137.
46. Broussolle C, Jeandidier N, Hanaire-Broutin H for The Evadiac Study Group: French multicentre experience with implantable insulin pumps. Lancet 1994, 343:514-515.
47. Gough D, Armour JC: Development of the implantable glucose sensor: what are the prospects and why is it taking so long? Diabetes 1995, 44:1005-1009.
48. Gough DA, Armour JC, Baker DA: Advances and prospects in glucose assay technology. Diabetologia 1997, 40(Suppl 2):S102-S107.
49. Potts RO, Tamada JA, Tierney MJ: Glucose monitoring by reverse iontophoresis. Diabetes Metab Res Rev 2002, 18(Suppl 1):S49-S53.
50. Pitzer KR, Desai S, Dunn T, Edelman S, Jayalakshmi Y, Kennedy J, Tamada JA, Potts RO: Detection of hypoglycemia with the Gluco Watch Biographer. Diabetes Care 2001, 24:881-885.
51. Fischer U: Fundamentals of glucose sensors. Diabet Med 1991, 8:309-321.
52. Ward WK, Jansen LB, Anderson E, Reach G, Klein JC, Wilson GS: A new amperometric glucose microsensor: in vitro and short-term in vivo evaluation. Biosens Bioelectron 2002, 17:181-189.
53. Galeska I, Hickey T, Moussy F, Kreutzer D, Papadimitrakopoulos F: Characterization and biocompatibility studies of novel humic acids based films as membrane material for an implantable glucose sensor. Biomacromolecules 2001, 2:1249-1255.
54. Chen X, Matsumoto N, Hu Y, Wilson GS: Electrochemically mediated electrodeposition/electropolymerization to yield a glucose microbiosensor with improved characteristics. Anal Chem 2002, 74:368-372.
55. Hoshi T, Saiki H, Kuwazawa S, Tsuchiya C, Chen Q, Anzai JI: Selective permeation of hydrogen peroxide through polyelectrolyte multilayer films and its use for amperometric biosensors. Anal Chem 2001, 73:5310-5315.
56. Yang H, Chung TD, Kim YT, Choi CA, Jun CH, Kim HC: Glucose sensor using a microfabricated electrode and electropolymerized bilayer films. Biosens Bioelectron 2002, 17:251-259.
57. Jin P, Yamaguchi A, Oi FA, Matsuo S, Tan J, Misawa H: Glucose sensing based on interdigitated array microelectrode. Anal Sci 2001, 17:841-846.
58. Bharathi S, Nogami M: A glucose biosensor based on electrodeposited biocomposites of gold nanoparticles and glucose oxidase enzyme. Analyst 2001, 126:1919-1922.
59. Mastrototaro JJ: The MiniMed continuous glucose monitoring system. Diabetes Technol Ther 2000, 2(Suppl 1):S13-S18.
60. Rebrin K, Steil GM, Van Antwerp WP, Mastrototaro JJ: Subcutaneous glucose predicts plasma glucose independent of insulin: implications for continuous monitoring. Am J Physiol 1999, 277:E561-E571.
61. Cheyne E, Kerr D: Making 'sense' of diabetes: using a continuous glucose sensor in clinical practice. Diabetes Metab Res Rev 2002, 18(Suppl 1):S43-S48.
62. Melki V, Hanaire-Broutin H: Indication of CGMS (Continuous Glucose Monitoring System) in the functional investigations of adult type 1 diabetic patients. Diabetes Metab 2001, 27:618-623.
63. Monsod TP, Flanagan DE, Rife F, Saenz R, Caprio S, Sherwin RS, Tamborlane WV: Do sensor glucose levels accurately predict plasma glucose concentrations during hypoglycemia and hyperinsulinemia. Diabetes Care 2002, 25:889-893.
64. Schmidtke DW, Freeland AC, Heller A, Bonnecaze RT: Measurement and modeling of the transient difference between blood and subcutaneous glucose concentrations in the rat after injection of insulin. Proc Natl Acad Sci USA 1998, 95:294-299.
65. Bode BW, Gross TM, Thornton KR, Mastrototaro JJ: Continuous glucose monitoring used to adjust diabetes therapy improves glycosylated hemoglobin: a pilot study. Diabetes Res Clin Pract 1999, 46:183-190.
66. Kaufman FR, Gibson LC, Halvorson M, Carpenter S, Fisher LK, Pitukcheewanont P: A pilot study of the continuous glucose monitoring system. Clinical decisions and glycemic control after its use in pediatric type 1 diabetic subjects. Diabetes Care 2001, 24:2030-2034.
67. Robert JJ: Continuous monitoring of blood glucose. Horm Res 2002, 57(Suppl 1):81-84.
68. Kerner W: Implantable glucose sensors: present status and future developments. Exp Clin Endocrinol Diabetes 2001, 109(Suppl 2):S341-S346.
69. Meyerhoff C, Bischof F, Sternberg F, Zier H, Pfeiffer EF: On line continuous monitoring of subcutaneous tissue glucose in men by combining portable glucosensor with microdialysis. Diabetologia 1992, 35:1087-1092.
70. Bolinder J, Hagstrom-Toft E, Ungerstedt U, Arner P: Self-monitoring of blood glucose in type 1 diabetic patients: comparison with continuous microdialysis measurements of glucose in subcutaneous adipose tissue during ordinary life conditions. Diabetes Care 1997, 20:64-70.
71. Freckmann G, Kalatz B, Pfeiffer B, Hoss U, Haug C: Recent advances in continuous glucose monitoring. Exp Clin Endocrinol Diabetes 2001, 109(Suppl 2):S347-S357.
72. Rhemrev-Boom RM, Tiessen RG, Jonker AA, Venema K, Vadgama P, Korf J: A lightweight measuring device for the continuous in vivo monitoring of glucose by means of ultraslow microdialysis in combination with a miniaturised flow-through biosensor. Clin Chim Acta 2002, 316:1-10.
73. Maran A, Crepaldi C, Tiengo A, Grassi G, Vitali E, Pagano G, Bistoni S, Calabrese G, Santeusanio F, Leonetti F et al.: Continuous subcutaneous glucose monitoring in diabetic patients: a multicenter analysis. Diabetes Care 2002, 25:347-352.
74. Wientjes KJ, Schoonen AJ: Determination of time delay between blood and interstitial adipose tissue glucose concentration change by microdialysis in healthy volunteers. Int J Artif Organs 2001, 24:884-889.
75. Updike SJ, Shults MC, Gilligan BJ, Rhodes RK: A subcutaneous glucose sensor with improved longevity, dynamic range, and stability of calibration. Diabetes Care 2000, 23:208-214.
76. Armour JC, Lucisano JY, McKean BD, Gough DA: Application of chronic intravascular glucose sensor in dogs. Diabetes 1990, 39:1519-1526.
77. Albisser AM, Leibel BS, Zinman B, Murray FT, Zingg W, Botz CK, Denoga A, Marliss EB: Studies with an artificial endocrine pancreas. Ann Intern Med 1977, 137:639-649.
78. DeVries JH, Eskes SA, Snoek FJ, Pouwer F, Van Ballegooie E, Spijker AJ, Kostense PJ, Seubert M, Heine RJ: Continuous intraperitoneal insulin infusion in patients with 'brittle' diabetes: favourable effects on glycaemic control and hospital stay. Diabet Med 2002, 19:496-501.
79. Ward WK, Jansen LB, Anderson E, Reach G, Klein JC, Wilson GS: A new amperometric glucose microsensor: in vitro and short-term in vivo evaluation. Biosens Bioelectron 2002, 17:181-189.
80. Metzger M, Leibowitz G, Wainstein J, Glaser B, Raz I: Reproducibility of glucose measurements using the glucose sensor. Diabetes Care 2002, 25:1185-1191.
81. Heinemann L, Koschinsky T: Continuous glucose monitoring: an overview of today's technologies and their clinical applications. Int J Clin Pract 2002, Suppl :75-79.